Quarterly report pursuant to Section 13 or 15(d)

11. SEGMENTS (Tables)

v3.7.0.1
11. SEGMENTS (Tables)
 6 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
Summarized segment financial information

Three Months Ended June 30, 2017
    ADMA BioManufacturing  

Plasma Collection

Centers

   Corporate   Consolidated
                 
Revenues   $ 539,223     $ 2,824,470     $ 35,708     $ 3,399,401  
                                 
Cost of product revenue     2,498,856       1,835,163       —         4,334,019  
                                 
Gross (loss) profit     (1,959,633 )     989,307       35,708       (934,618 )
                                 
Loss from operations     (3,118,300 )     (610,864 )     (4,672,704 )     (8,401,868 )
                                 
Other expense, net     (61,987 )     —         (572,640 )     (634,627 )
                                 
Net loss     (3,180,287 )     (610,864 )     (5,245,344 )     (9,036,495 )
                                 
Total assets     65,913,839       2,101,977       16,623,437       84,639,253  
                                 
Depreciation and amortization expense     158,398       103,703       15,031       277,132  

 

Three Months Ended June 30, 2016
    ADMA BioManufacturing  

Plasma Collection

Centers

   Corporate   Consolidated
                 
Revenues   $ —       $ 2,236,036     $ 35,708     $ 2,271,744  
                                 
Cost of product revenue     —         1,344,241       —         1,344,241  
                                 
Gross profit     —         891,795       35,708       927,503  
                                 
Loss from operations     —         (402,507 )     (5,088,343 )     (5,490,850 )
                                 
Other expense, net     —         —         (521,485 )     (521,485 )
                                 
Net loss     —         (402,507 )     (5,609,828 )     (6,012,335 )
      —                            
Total assets     —         2,509,903       29,232,086       31,741,989  
                                 
Depreciation and amortization expense     —         102,330       13,671       116,001  

 

Six Months Ended June 30, 2017
    ADMA BioManufacturing  

Plasma Collection

Centers

   Corporate   Consolidated
                 
Revenues   $ 539,223     $ 5,417,632     $ 71,417     $ 6,028,272  
                                 
Cost of product revenue     2,498,856       3,451,450       —         5,950,306  
                                 
Gross profit     (1,959,633 )     1,966,182       71,417       77,966  
                                 
Loss from operations     (3,118,300 )     (1,113,464 )     (10,107,107 )     (14,338,871 )
                                 
Other expense, net     (61,987 )     —         (1,172,600 )     (1,234,587 )
                                 
Net loss     (3,180,287 )     (1,113,464 )     (11,279,707 )     (15,573,458 )
                                 
Capital expenditures     —         81,294       15,263       96,557  
                                 
Depreciation and amortization expense     158,398       207,343       29,453       395,194  

 

Six Months Ended June 30, 2016
    ADMA BioManufacturing  

Plasma Collection

Centers

   Corporate   Consolidated
                 
Revenues   $ —       $ 4,324,213     $ 71,417     $ 4,395,630  
                                 
Cost of product revenue     —         2,610,662       —         2,610,662  
                                 
Gross profit     —         1,713,551       71,417       1,784,968  
                                 
Loss from operations     —         (861,169 )     (8,788,217 )     (9,649,386 )
                                 
Other expense, net     —         —         (975,418 )     (975,418 )
                                 
Net loss     —         (861,169 )     (9,763,635 )     (10,624,804 )
      —                            
Capital expeditures     —         32,733       25,301       58,034  
                                 
Depreciation and amortization expense     —         207,519       26,875       234,394